On the question of which vaccine formulation to choose, ICMR said the Northern Hemisphere vaccine is preferable, but the Southern Hemisphere version is a suitable substitute if the preferred one isn’t available. Crucially, the council stressed that both formulations are effective against the H1N1 strain currently in circulation, meaning availability of a specific version shouldn’t be a barrier to getting vaccinated.
